10 completed, 3 terminated, 1 unknown, 1 withdrawn. 5 Phase 4, 4 Not applicable, 3 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Terminated 2, Completed 1, Unknown 1, Withdrawn 1 |
| Not applicable | 4 | Completed 3, Terminated 1 |
| Phase 3 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Serevent: new trials by email Literature Review of Serevent trials Research Report on Serevent
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ANTES B+ Clinical Trial Trelegy Ellipta 100/62.5/25Mcg Inh 30D, Brimica, Duaklir - Chronic Obstructive Pulmonary Disease | Phase 4 | Terminated | Fundacio Privada Mon Clinic Barcelona | 48 | 2024-02-29 | 2025-08-14 |
| Inhaled Long-acting Bronchodilators With or Without Inhaled Glucocorticosteroids for Preventing Hospitalizations and Death in Elderly Patients With Chronic Obstructive Pulmonary Disease Bronchodilator Agents - Pulmonary Disease, Chronic Obstructive | Phase 4 | Terminated | Università degli Studi di Ferrara | 843 | 2018-11-11 | 2022-12-28 |
| Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers With Charcoal Block Fluticasone propionate, Salmeterol (as xinafoate) - Asthma, Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Completed | Intech Biopharm Ltd. | 45 | 2014-08-01 | 2015-06-09 |
| Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary Disease arformoterol, salmeterol - Chronic Obstructive Pulmonary Disease | Not applicable | Completed | Dartmouth-Hitchcock Medical Center | 20 | 2011-07-01 | 2013-08-07 |
| Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography Nebulized arformoterol, Salmeterol - Chronic Obstructive Pulmonary Disease, COPD | Phase 4 | Unknown | University of California, Los Angeles | 20 | 2011-06-01 | 2012-07-20 |
| Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT) Tiotropium, Salmeterol, Formoterol - Asthma | Phase 3 | Completed | Brigham and Women's Hospital | 1070 | 2011-03-30 | 2018-03-30 |
| The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations tiotropium bromide, Salmeterol, Formoterol - Asthma | Not applicable | Terminated | Brigham and Women's Hospital | 255 | 2008-06-01 | 2017-05-31 |
| Tiotropium for Smoking Asthmatics Study tiotropium, long acting beta agonist - Asthma | Phase 4 | Withdrawn | University of Alberta | 2007-11-01 | 2016-05-26 | |
| Interactive Acute Smooth Muscle Effects of Salmeterol and Fluticasone in the Airway fluticasone, placebo inhalation, Salmeterol - Asthma | Not applicable | Completed | University of Miami | 14 | 2007-05-01 | 2016-06-30 |
| Dose Ranging Study for Indacaterol in Japanese Asthma Patients Indacaterol, Placebo, Salmeterol - Asthma | Phase 2 | Completed | Novartis Pharmaceuticals | 41 | 2006-11-01 | 2011-08-17 |
| Effects of Salmeterol on Walking Capacity in Patients With COPD Placebo, Salmeterol diskus inhalation powder - Chronic Obstructive Pulmonary Disease | Phase 4 | Completed | Laval University | 28 | 2006-05-01 | 2007-09-06 |
| Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in Asthma Salmeterol and Salmeterol / Fluticasone - Allergic Asthma | Not applicable | Completed | University of Rostock | 35 | 2005-09-01 | 2008-08-21 |
| Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE) salmeterol, beclomethasone HFA - Asthma | Phase 3 | Completed | Milton S. Hershey Medical Center | 87 | 2004-12-01 | 2018-01-23 |
| A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Arformoterol tartrate inhalation solution, Salmeterol MDI, Placebo - COPD | Phase 3 | Completed | Sumitomo Pharma America, Inc. | 717 | 2002-02-01 | 2012-11-02 |
| Comparison of Two Treatment Regimens in Asthmatic Patients first prescription of montelukast, first prescription of salmeterol - Asthma | Completed | Medical University of Lodz | 132 | 1995-04-01 | 2012-01-12 |
Asthma (8) · Pulmonary Disease, Chronic Obstructive (7) · Bronchitis, Chronic (1) · Dyspnea (1) · Emphysema (1) · Motor Activity (1) · Respiratory Hypersensitivity (1) · Smoking (1)
Brigham and Women's Hospital (2) · Dartmouth-Hitchcock Medical Center (1) · Fundacio Privada Mon Clinic Barcelona (1) · Intech Biopharm Ltd. (1) · Laval University (1) · Medical University of Lodz (1) · Milton S. Hershey Medical Center (1) · Novartis Pharmaceuticals (1) · Sumitomo Pharma America, Inc. (1) · University of Alberta (1) · University of California, Los Angeles (1) · University of Miami (1) · University of Rostock (1) · Università degli Studi di Ferrara (1)
United States (6) · Canada (2) · Germany (1) · Italy (1) · Japan (1) · Spain (1) · Taiwan (1)
Elliot Israel, MD (2) · Adam Wanner, MD (1) · Darcy Marciniuk, MD (1) · Dilini Vethanayagam, MD (1) · Donald A Mahler, M.D. (1) · Elliot Israel (1) · Harissios Vliagoftis, MD (1) · Homer Boushey (1) · Irvin Mayers, MD, FRCPC (1) · Johann C. Virchow, MD, FCCP (1) · Mario Castro (1) · Rafal Pawliczak, MD PhD (1) · Richard Martin (1)
PMID 19237390, PMID 19932356, PMID 21980058, PMID 23745526, PMID 26505596, PMID 36472162
2023 (1), U10HL074073 (1), U10HL074204 (1), U10HL074208 (1), U10HL074212 (1), U10HL074218 (1), U10HL074225 (1), U10HL074227 (1), U10HL074231 (1)